BioXcel Therapeutics, Inc. Common Stock (NASDAQ: BTAI) last traded at $0.804, up 0.66% on the session. The quote above updates while this page is open; the figures below are drawn from BioXcel Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
BioXcel Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker BTAI. Its market capitalisation is $25.16 million.
Valuation measures for BioXcel Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $25.16M |
|---|---|
| Enterprise value | $156.58M |
| Price / sales | 33.91 |
| Beta | 2.04 |
Trailing-twelve-month figures tagged in BioXcel Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $742.0K |
|---|---|
| Net income (TTM) | -$70.86M |
| EPS (TTM) | -$2.81 |
| Operating margin | -6054.72% |
| Cash | $12.84M |
Range and volume for BTAI over the past 52 weeks.
| 52-week high | $5.25 |
|---|---|
| 52-week low | $0.737 |
| Volume | 1.22M |
| Average volume | 1.01M |
| Previous close | $0.798 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.